Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3V0V

Fab WN1 222-5 unliganded

Summary for 3V0V
Entry DOI10.2210/pdb3v0v/pdb
Related3V0W
DescriptorWN1 222-5 Fab (IgG2a) light chain, WN1 222-5 Fab (IgG2a) heavy chain (3 entities in total)
Functional Keywordsbeta sheets, antibody, fab, immune system
Biological sourceMus musculus
More
Total number of polymer chains4
Total formula weight93616.17
Authors
Gomery, K.,Evans, S.V. (deposition date: 2011-12-08, release date: 2012-12-05, Last modification date: 2024-10-16)
Primary citationGomery, K.,Muller-Loennies, S.,Brooks, C.L.,Brade, L.,Kosma, P.,Di Padova, F.,Brade, H.,Evans, S.V.
Antibody WN1 222-5 mimics Toll-like receptor 4 binding in the recognition of LPS.
Proc.Natl.Acad.Sci.USA, 109:20877-20882, 2012
Cited by
PubMed Abstract: Escherichia coli infections, a leading cause of septic shock, remain a major threat to human health because of the fatal action to endotoxin (LPS). Therapeutic attempts to neutralize endotoxin currently focus on inhibiting the interaction of the toxic component lipid A with myeloid differentiating factor 2, which forms a trimeric complex together with Toll-like receptor 4 to induce immune cell activation. The 1.73-Å resolution structure of the unique endotoxin-neutralizing protective antibody WN1 222-5 in complex with the core region shows that it recognizes LPS of all E. coli serovars in a manner similar to Toll-like receptor 4, revealing that protection can be achieved by targeting the inner core of LPS and that recognition of lipid A is not required. Such interference with Toll-like receptor complex formation opens new paths for antibody sepsis therapy independent of lipid A antagonists.
PubMed: 23184990
DOI: 10.1073/pnas.1209253109
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.13 Å)
Structure validation

239149

数据于2025-07-23公开中

PDB statisticsPDBj update infoContact PDBjnumon